To be presented at CAR-TCR Summit 2022.
Register below to receive a video of the presentation.
Impact of Closed, Continuous Perfusion Dose-Scale Bioreactors on Process Development for Personalized Cell Therapy
- Efficient, cost-effective and reproducible process development/optimization of cell therapy manufacturing protocols
- Functionally closed and automated bioreactor platform with Integrated Microfluidics, Sensors, Pumps, and Filters
- Perfusion-based, high density culture for process development at mL dose scale